|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US6893625B1
(en)
|
1986-10-27 |
2005-05-17 |
Royalty Pharma Finance Trust |
Chimeric antibody with specificity to human B cell surface antigen
|
|
ES2150428T3
(es)
|
1987-04-27 |
2000-12-01 |
Unilever Nv |
Ensayos de union especifica.
|
|
US5120643A
(en)
|
1987-07-13 |
1992-06-09 |
Abbott Laboratories |
Process for immunochromatography with colloidal particles
|
|
AU2684488A
(en)
|
1988-06-27 |
1990-01-04 |
Carter-Wallace, Inc. |
Test device and method for colored particle immunoassay
|
|
US5252496A
(en)
|
1989-12-18 |
1993-10-12 |
Princeton Biomeditech Corporation |
Carbon black immunochemical label
|
|
AU1331892A
(en)
|
1991-02-01 |
1992-09-07 |
Coulter Corporation |
Method of producing f(ab')2 fragments of immunoglobulins
|
|
FI941572L
(fi)
|
1991-10-07 |
1994-05-27 |
Oncologix Inc |
Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
|
|
US6034078A
(en)
|
1992-05-29 |
2000-03-07 |
Eli Lilly And Company Limited |
Thienobenzodiazepine compounds
|
|
DE69329887T2
(de)
|
1992-05-29 |
2001-05-23 |
Eli Lilly And Co., Ltd. |
Thienobenzodiazepinderivate zur Behandlung von Störungen des Zentralnervensystems
|
|
US5527709A
(en)
|
1992-06-26 |
1996-06-18 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Immunoassays with labeled thyronine hapten analogues
|
|
US5642870A
(en)
|
1992-08-05 |
1997-07-01 |
Sargis; Ike |
Switch stand
|
|
US5395933A
(en)
|
1992-08-07 |
1995-03-07 |
Eastman Kodak Company |
Carbamazepine hapten analogues
|
|
WO1995034652A1
(en)
|
1994-06-10 |
1995-12-21 |
Oklahoma Medical Research Foundation |
Calcium binding recombinant antibody against protein c
|
|
EG23659A
(en)
|
1995-03-24 |
2007-03-26 |
Lilly Co Eli |
Process and crystal forms of methyl-thieno-benzodiazepine
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US5761894A
(en)
|
1996-09-25 |
1998-06-09 |
Magic Circle Corporation |
Grass striping attachment for lawn mowers
|
|
AU8148898A
(en)
|
1997-06-23 |
1999-01-04 |
Luminex Corporation |
Interlaced lasers for multiple fluorescence measurement
|
|
US6830731B1
(en)
|
1998-01-05 |
2004-12-14 |
Biosite, Inc. |
Immunoassay fluorometer
|
|
US6362371B1
(en)
|
1998-06-08 |
2002-03-26 |
Advanced Medicine, Inc. |
β2- adrenergic receptor agonists
|
|
US20030143233A1
(en)
*
|
1999-06-07 |
2003-07-31 |
Neorx Corporation |
Streptavidin expressed gene fusions and methods of use thereof
|
|
UA76708C2
(uk)
|
1999-12-08 |
2006-09-15 |
Сінгента Патисипейшонс Аг |
Антитіло, яке застосовується в імунологічному аналізі зразка для визначення неонікотиноїдного інсектициду, білковий кон'югат для одержання антитіла, спосіб визначення концентрації неонікотиноїдного інсектициду в зразку та набір для визначення кількості неонікотиноїдного інсектициду
|
|
US7163681B2
(en)
|
2000-08-07 |
2007-01-16 |
Centocor, Inc. |
Anti-integrin antibodies, compositions, methods and uses
|
|
US6958156B2
(en)
|
2000-12-15 |
2005-10-25 |
Vyrex Corporation |
Isoflavone derivatives
|
|
EP1476120B1
(en)
|
2002-02-21 |
2010-09-29 |
Duke University |
Treatment methods using anti-cd22 antibodies
|
|
EP2316468A1
(en)
|
2002-02-22 |
2011-05-04 |
Shire LLC |
Delivery system and methods for protecting and administering dextroamphetamine
|
|
EP1492794B1
(en)
|
2002-03-28 |
2007-12-12 |
Eli Lilly And Company |
Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
|
|
SE0201738D0
(sv)
|
2002-06-07 |
2002-06-07 |
Aamic Ab |
Micro-fluid structures
|
|
CA2494109A1
(en)
|
2002-07-29 |
2004-02-05 |
Potomac, Pharma, Llc. |
Antipsychotic combination therapies and compositions of an alpha-2 adrenergic receptor antagonist and an atypical antipsychotic neuroleptic
|
|
ES2285227T3
(es)
*
|
2002-08-05 |
2007-11-16 |
Eli Lilly And Company |
Arilbenzodiazepinas sustituidas con piperazina.
|
|
KR101351122B1
(ko)
*
|
2003-05-09 |
2014-01-14 |
듀크 유니버시티 |
Ｃｄ２０-특이적 항체 및 이를 이용한 방법
|
|
CA2536073A1
(en)
|
2003-08-18 |
2005-02-24 |
H. Lundbeck A/S |
Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
|
|
PT1664007E
(pt)
|
2003-09-23 |
2010-02-15 |
Fermion Oy |
Preparação de quetiapina
|
|
KR20140015122A
(ko)
|
2003-10-01 |
2014-02-06 |
아돌로 코포레이션 |
스피로시클릭 헤테로시클릭 유도체 및 이의 사용 방법
|
|
DE602004024236D1
(en)
|
2003-12-12 |
2009-12-31 |
Inverness Medical Switzerland |
Assay
|
|
SE0400662D0
(sv)
|
2004-03-24 |
2004-03-24 |
Aamic Ab |
Assay device and method
|
|
WO2005103250A1
(ja)
|
2004-04-26 |
2005-11-03 |
Takami Matsuyama |
葉酸リセプターベータ（FR-β）に対する単クローン抗体を含有する治療薬
|
|
SE527036C2
(sv)
|
2004-06-02 |
2005-12-13 |
Aamic Ab |
Analysanordning med reglerat flöde och motsvarande förfarande
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
US20060235005A1
(en)
|
2005-04-14 |
2006-10-19 |
Oak Labs, Corp. |
Use of phosphodiesterase 5 (PDE5) inhibitors in the treatment of schizophrenia
|
|
SE529254C2
(sv)
|
2005-06-17 |
2007-06-12 |
Aamic Ab |
Optiskt testsystem
|
|
SE528233C2
(sv)
|
2005-06-20 |
2006-09-26 |
Aamic Ab |
Metod och medel för att åstadkomma vätsketransport
|
|
SE529711C2
(sv)
|
2006-03-22 |
2007-11-06 |
Aamic Ab |
Fluorescensläsare
|
|
US8975374B2
(en)
|
2006-10-20 |
2015-03-10 |
Chugai Seiyaku Kabushiki Kaisha |
Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
|
|
EP2077860B1
(en)
*
|
2006-10-25 |
2014-04-09 |
Ramot at Tel-Aviv University Ltd |
Psychotropic agents having glutamate nmda activity
|
|
ES2405364T3
(es)
|
2006-12-29 |
2013-05-30 |
Abbott Laboratories |
Ensayo diagnóstico para la detección de una molécula o fármaco en sangre entera
|
|
JP2010540920A
(ja)
|
2007-09-27 |
2010-12-24 |
ノバルティス アーゲー |
薬物モニタリングアッセイ
|
|
CN101945894A
(zh)
*
|
2007-12-13 |
2011-01-12 |
积水医疗株式会社 |
抗氧氟沙星单克隆抗体和使用其的氧氟沙星免疫测定
|
|
KR101706789B1
(ko)
|
2008-07-21 |
2017-02-14 |
프로비오드룩 아게 |
진단용 항체 검사법
|
|
MX2011001384A
(es)
|
2008-08-06 |
2011-09-27 |
Gosforth Ct Holdings Pty Ltd |
Composiciones y metodos para tratar trastornos psiquiatricos.
|
|
WO2010033270A1
(en)
|
2008-09-17 |
2010-03-25 |
Auspex Pharmaceuticals, Inc. |
Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
|
|
TW201020258A
(en)
|
2008-10-14 |
2010-06-01 |
Astrazeneca Ab |
Chemical compounds 542
|
|
US8168756B2
(en)
*
|
2008-10-24 |
2012-05-01 |
Ark Diagnostics, Inc. |
Levetiracetam immunoassays
|
|
WO2010096117A2
(en)
|
2008-10-29 |
2010-08-26 |
Janssen Pharmaceutica Nv |
Methods of treating psychosis and schizophrenia based on polymorphisms in the erbb4 gene
|
|
EP2194048A1
(en)
|
2008-12-02 |
2010-06-09 |
Dirk Sartor |
Nitrate esters for the treatment of vascular and metabolic diseases
|
|
US8480333B2
(en)
|
2008-12-26 |
2013-07-09 |
Steven Edward DeMay |
Frame rail assemblies and interlocking frame rail systems
|
|
NZ594071A
(en)
|
2009-01-26 |
2013-01-25 |
Egalet Ltd |
Controlled release formulations comprising morphine sulphate for continuous treatment of pain
|
|
BRPI1009454A2
(pt)
|
2009-03-10 |
2019-09-24 |
Baylor Res Institute |
vacinas contra o câncer direcionadas a células apresentadoras de antígenos
|
|
EP2488871B1
(en)
|
2009-10-16 |
2017-01-04 |
Åmic AB |
An assay method involving the use of magnetic particles
|
|
EP2325322A1
(en)
*
|
2009-11-23 |
2011-05-25 |
4-Antibody AG |
Retroviral vector particles and methods for their generation and use
|
|
CN107714703A
(zh)
|
2009-12-31 |
2018-02-23 |
凯姆制药公司 |
喹硫平的氨基酸缀合物、其制备和使用方法
|
|
RS58335B1
(sr)
|
2010-03-11 |
2019-03-29 |
Kempharm Inc |
Konjugati kvetiapina sa masnom kiselinom, proces za njihovo dobijanje i njihova primena
|
|
US8114621B2
(en)
|
2010-03-12 |
2012-02-14 |
Saladax Biomedical Inc. |
Lenalidomide and thalidomide immunoassays
|
|
US8088594B2
(en)
|
2010-03-16 |
2012-01-03 |
Saladax Biomedical Inc. |
Risperidone immunoassay
|
|
WO2011159537A2
(en)
|
2010-06-15 |
2011-12-22 |
The Regents Of The University Of California |
Method and device for analyte detection
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
US9156822B2
(en)
|
2010-07-02 |
2015-10-13 |
The University Of North Carolina At Chapel Hill |
Functionally selective ligands of dopamine D2 receptors
|
|
US8623324B2
(en)
|
2010-07-21 |
2014-01-07 |
Aat Bioquest Inc. |
Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates
|
|
CN102276592B
(zh)
*
|
2011-06-17 |
2013-10-16 |
大连理工大学 |
一种奥氮平有关物质及其制备方法、分析方法
|
|
CN102276624B
(zh)
*
|
2011-06-17 |
2013-10-16 |
大连理工大学 |
一种奥氮平有关物质及其制备方法和高效液相色谱分析方法
|
|
WO2013088255A1
(en)
|
2011-12-15 |
2013-06-20 |
Alkermes Pharma Ireland Limited |
Prodrugs of secondary amine compounds
|
|
BR112015003393A2
(pt)
|
2012-08-16 |
2017-07-04 |
Janssen Pharmaceutica Nv |
pirazóis substituídos como bloqueadores de canal de cálcio de tipo-n
|
|
PL2888373T3
(pl)
|
2012-08-21 |
2018-08-31 |
Janssen Pharmaceutica Nv |
Przeciwciała dla arypiprazolu i ich zastosowanie
|
|
WO2014031645A1
(en)
|
2012-08-21 |
2014-02-27 |
Ortho-Clinical Diagnostics, Inc |
Antibodies to risperidone haptens and use thereof
|
|
AU2013305970B2
(en)
|
2012-08-21 |
2017-08-17 |
Saladax Biomedical Inc. |
Antibodies to aripiprazole haptens and use thereof
|
|
ES3057437T3
(en)
|
2012-08-21 |
2026-03-02 |
Janssen Pharmaceutica Nv |
Antibodies to olanzapine haptens and use thereof
|
|
ES2701062T3
(es)
*
|
2012-08-21 |
2019-02-20 |
Janssen Pharmaceutica Nv |
Haptenos de olanzapina
|
|
WO2014031584A1
(en)
|
2012-08-21 |
2014-02-27 |
Janssen Pharmaceutica Nv |
Haptens of aripiprazole and their use in immunoassays
|
|
ES2654413T3
(es)
|
2012-08-21 |
2018-02-13 |
Janssen Pharmaceutica, N.V. |
Anticuerpos a quetiapina y uso de los mismos
|
|
PL2888286T3
(pl)
|
2012-08-21 |
2018-07-31 |
Janssen Pharmaceutica Nv |
Przeciwciała skierowane przeciwko haptenom kwetiapinowym i ich zastosowanie
|
|
ES2870004T3
(es)
|
2012-08-21 |
2021-10-26 |
Janssen Pharmaceutica Nv |
Anticuerpos contra la risperidona y uso de los mismos
|
|
CA2882560C
(en)
|
2012-08-21 |
2020-10-27 |
Ortho-Clinical Diagnostics, Inc. |
Haptens of risperidone and paliperidone for use in immunoassays
|
|
PT3305784T
(pt)
|
2012-08-21 |
2020-10-23 |
Janssen Pharmaceutica Nv |
Haptenos de quetiapina para utilização em ensaios imunológicos
|
|
JP2015529199A
(ja)
|
2012-08-21 |
2015-10-05 |
オルソ−クリニカル ダイアグノスティクス，インコーポレイティド |
パリペリドンハプテンに対する抗体及びその使用
|
|
WO2014031662A2
(en)
*
|
2012-08-21 |
2014-02-27 |
Ortho-Clinical Diagnostics, Inc |
Antibodies to olanzapine and use thereof
|
|
AU2013305930B2
(en)
|
2012-08-21 |
2017-08-24 |
Saladax Biomedical Inc. |
Haptens of paliperidone
|
|
EP2888277A4
(en)
|
2012-08-21 |
2016-05-18 |
Ortho Clinical Diagnostics Inc |
ANTIBODIES AGAINST PALIPERIDONE AND USE THEREOF
|
|
US9453002B2
(en)
|
2013-08-16 |
2016-09-27 |
Janssen Pharmaceutica Nv |
Substituted imidazoles as N-type calcium channel blockers
|